• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

MultiCare Health Taps IllumiCare to Tackle Clinical Waste with AI

by Fred Pennic 01/21/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– MultiCare Health System, a large healthcare network in Tacoma, Washington, has partnered with IllumiCare to integrate its clinical decision support (CDS) solution directly into its Epic electronic health record (EHR) system. 

– The integration provides clinicians with real-time recommendations at the point of care, helping them make more informed decisions about medications, lab tests, and imaging studies.

Targeting Inefficiencies in Healthcare Delivery

Clinical waste takes many forms in healthcare, including:

  • Unnecessary or redundant tests and procedures: Ordering repetitive lab tests or duplicate imaging studies.
  • Inappropriate medication prescribing: Prescribing expensive medications when equally effective, more affordable alternatives are available.
  • Inefficient workflows: Processes that lead to delays in care or unnecessary resource utilization.

IllumiCare’s CDS solution addresses these inefficiencies by providing clinicians with evidence-based recommendations directly within their workflow. This helps them avoid unnecessary costs and improve the quality of care.

Significant Results at MultiCare Health System

MultiCare has achieved impressive results with IllumiCare’s CDS integration:

  • High acceptance rate: Clinicians have accepted 26% of the recommendations provided by the system, exceeding national averages.
  • Reduced medication costs: The acceptance rate for medication recommendations is 23%, leading to significant cost savings.
  • Fewer unnecessary lab tests: The acceptance rate for lab order recommendations is 36%, reducing unnecessary testing and improving efficiency.

IllumiCare’s real-time analytics revealed that 82% of intravenous sodium bicarbonate use at MultiCare lacked clinical necessity. This unnecessary use costs the hospital $153 per dose, contributing to significant avoidable spending. By providing clinicians with real-time guidance, IllumiCare helped reduce inappropriate use and optimize costs.

Expanding the Program for Continued Improvement

Building on its success, MultiCare is expanding its use of IllumiCare’s CDS solution to include more users and additional clinical categories, such as radiology. This expansion will further enhance the system’s ability to reduce clinical waste and improve care efficiency.

“Reducing clinical waste benefits the healthcare system by doing more than simply saving money—it’s optimizing care delivery and reducing inefficiencies that offer no added value,” said G.T. LaBorde, CEO of IllumiCare. “By equipping providers with actionable data in real-time, we’re helping them make decisions that benefit both their patients and their hospitals’ bottom lines.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |